Literature DB >> 34139350

Role of endolysosome function in iron metabolism and brain carcinogenesis.

Peter W Halcrow1, Miranda L Lynch2, Jonathan D Geiger1, Joyce E Ohm3.   

Abstract

Iron, the most abundant metal in human brain, is an essential microelement that regulates numerous cellular mechanisms. Some key physiological roles of iron include oxidative phosphorylation and ATP production, embryonic neuronal development, formation of iron-sulfur clusters, and the regulation of enzymes involved in DNA synthesis and repair. Because of its physiological and pathological importance, iron homeostasis must be tightly regulated by balancing its uptake, transport, and storage. Endosomes and lysosomes (endolysosomes) are acidic organelles known to contain readily releasable stores of various cations including iron and other metals. Increased levels of ferrous (Fe2+) iron can generate reactive oxygen species (ROS) via Fenton chemistry reactions and these increases can damage mitochondria and genomic DNA as well as promote carcinogenesis. Accumulation of iron in the brain has been linked with aging, diet, disease, and cerebral hemorrhage. Further, deregulation of brain iron metabolism has been implicated in carcinogenesis and may be a contributing factor to the increased incidence of brain tumors around the world. Here, we provide insight into mechanisms by which iron accumulation in endolysosomes is altered by pH and lysosome membrane permeabilization. Such events generate excess ROS resulting in mitochondrial DNA damage, fission, and dysfunction, as well as DNA oxidative damage in the nucleus; all of which promote carcinogenesis. A better understanding of the roles that endolysosome iron plays in carcinogenesis may help better inform the development of strategic therapeutic options for cancer treatment and prevention.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Brain; Carcinogens; Endolysosomes; Iron; ROS

Mesh:

Substances:

Year:  2021        PMID: 34139350      PMCID: PMC8627927          DOI: 10.1016/j.semcancer.2021.06.013

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  269 in total

1.  Ceruloplasmin gene expression in the murine central nervous system.

Authors:  L W Klomp; Z S Farhangrazi; L L Dugan; J D Gitlin
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization.

Authors:  Ann Cassidy-Stone; Jerry E Chipuk; Elena Ingerman; Cheng Song; Choong Yoo; Tomomi Kuwana; Mark J Kurth; Jared T Shaw; Jenny E Hinshaw; Douglas R Green; Jodi Nunnari
Journal:  Dev Cell       Date:  2008-02       Impact factor: 12.270

3.  H-ferritin is the major source of iron for oligodendrocytes.

Authors:  Bozho Todorich; Xuesheng Zhang; James R Connor
Journal:  Glia       Date:  2011-03-28       Impact factor: 7.452

4.  Effects of nicotine on the fine structure of cultivated mouse peritoneal macrophages.

Authors:  J Thyberg; U Hedin; K Stenseth; J Nilsson
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1983-01

Review 5.  High-field magnetic resonance imaging of brain iron: birth of a biomarker?

Authors:  John F Schenck; Earl A Zimmerman
Journal:  NMR Biomed       Date:  2004-11       Impact factor: 4.044

6.  Effects of atypical antioxidative agents, S-nitrosoglutathione and manganese, on brain lipid peroxidation induced by iron leaking from tissue disruption.

Authors:  P Rauhala; C C Chiueh
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

7.  Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke.

Authors:  Leah R Hanson; Annina Roeytenberg; Paula M Martinez; Valerie G Coppes; Donald C Sweet; Reshma J Rao; Dianne L Marti; John D Hoekman; Rachel B Matthews; William H Frey; S Scott Panter
Journal:  J Pharmacol Exp Ther       Date:  2009-06-09       Impact factor: 4.030

8.  Acidic extracellular microenvironment and cancer.

Authors:  Yasumasa Kato; Shigeyuki Ozawa; Chihiro Miyamoto; Yojiro Maehata; Atsuko Suzuki; Toyonobu Maeda; Yuh Baba
Journal:  Cancer Cell Int       Date:  2013-09-03       Impact factor: 5.722

9.  Mitochondrial control by DRP1 in brain tumor initiating cells.

Authors:  Qi Xie; Qiulian Wu; Craig M Horbinski; William A Flavahan; Kailin Yang; Wenchao Zhou; Stephen M Dombrowski; Zhi Huang; Xiaoguang Fang; Yu Shi; Ashley N Ferguson; David F Kashatus; Shideng Bao; Jeremy N Rich
Journal:  Nat Neurosci       Date:  2015-03-02       Impact factor: 24.884

Review 10.  Lessons from the Discovery of Mitochondrial Fragmentation (Fission): A Review and Update.

Authors:  Dmitry B Zorov; Ivan A Vorobjev; Vasily A Popkov; Valentina A Babenko; Ljubava D Zorova; Irina B Pevzner; Denis N Silachev; Savva D Zorov; Nadezda V Andrianova; Egor Y Plotnikov
Journal:  Cells       Date:  2019-02-19       Impact factor: 6.600

View more
  2 in total

1.  Heterogeneity of ferrous iron-containing endolysosomes and effects of endolysosome iron on endolysosome numbers, sizes, and localization patterns.

Authors:  Peter W Halcrow; Nirmal Kumar; Zahra Afghah; Jalyn P Fischer; Nabab Khan; Xuesong Chen; Olimpia Meucci; Jonathan D Geiger
Journal:  J Neurochem       Date:  2022-02-23       Impact factor: 5.546

2.  Endolysosome Iron Chelation Inhibits HIV-1 Protein-Induced Endolysosome De-Acidification-Induced Increases in Mitochondrial Fragmentation, Mitophagy, and Cell Death.

Authors:  Peter W Halcrow; Nirmal Kumar; Darius N K Quansah; Aparajita Baral; Braelyn Liang; Jonathan D Geiger
Journal:  Cells       Date:  2022-05-31       Impact factor: 7.666

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.